28 / 39
Page 86
Notes:
allied
academies
February 28-March 01, 2019 | Paris, France
Palliative Care, Obstetrics and Gynecology
Stroke and Clinical Trials
International Conference on
Joint Event on
International Conference on
&
Journal of Research and Reports in Gynecology and Obstetrics | Volume: 3
Treatment of pain in cancer: Towards personalised medicine
Marieke van den Beuken-van Everdingen
Maastricht University Hospital, Netherland
D
espite increased attention to cancer pain, pain prevalence
in patients with cancer has not improved over the last
decade. One third of cancer patients on anti-cancer therapy
and half of patients with advanced disease still suffer from
moderate to severe pain. In this lecture the possible reasons
for this lack of improvement will be discussed: barriers
for patients to discuss pain with clinicians spontaneously;
pain measurement instruments are not routinely used in
daily practice; limited knowledge concerning assessment
of under treatment; changes in patients characteristics,
including ageing of the population; limitations of available
pharmacological treatment, lack of robust literature on
effectiveness and a one-opioid-fits-all mentality. This lecture
will elaborate on future perspectives and the development
of personalised medicine in cancer pain. Based on recent
research two ways to personalised medicine in pain
treatment will be explored: the search for predictors “which
patient-pain characteristics combination will benefit from
what medication” and the advances in pharmacogenetics.
e:
m.vanden.beuken@mumc.nlRes Rep Gynaecol Obstet, Volume 3
DOI: 10.4066/2591-7366-C1-003